Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

Glypican 3 Antikörper (AA 511-580)

Dieses Anti-Glypican 3-Antikörper ist ein Maus Monoklonal-Antikörper zur Detektion von Glypican 3 in IF, FACS und IHC (p). Geeignet für Human.
Produktnummer ABIN3024886

Kurzübersicht für Glypican 3 Antikörper (AA 511-580) (ABIN3024886)

Target

Alle Glypican 3 (GPC3) Antikörper anzeigen
Glypican 3 (GPC3)

Reaktivität

  • 184
  • 64
  • 50
  • 4
  • 2
  • 2
  • 2
  • 2
  • 1
  • 1
  • 1
Human

Wirt

  • 111
  • 72
  • 5
  • 2
  • 1
  • 1
Maus

Klonalität

  • 96
  • 88
  • 5
Monoklonal

Konjugat

  • 87
  • 15
  • 7
  • 7
  • 6
  • 6
  • 6
  • 6
  • 6
  • 6
  • 6
  • 6
  • 6
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
Dieser Glypican 3 Antikörper ist unkonjugiert

Applikation

  • 96
  • 87
  • 84
  • 69
  • 58
  • 30
  • 26
  • 17
  • 15
  • 15
  • 6
  • 2
  • 2
  • 1
  • 1
Immunofluorescence (IF), Flow Cytometry (FACS), Immunohistochemistry (Paraffin-embedded Sections) (IHC (p))

Klon

1G12-GPC3-863
  • Bindungsspezifität

    • 21
    • 16
    • 12
    • 8
    • 7
    • 7
    • 6
    • 5
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    AA 511-580

    Aufreinigung

    Protein G affinity chromatography

    Immunogen

    A recombinant fragment containing amino acids 511-580 of human GPC3 (1G12) and recombinant full-length protein (GPC3/863) were used as the immunogen for the Glypican-3 antibody cocktail.

    Isotyp

    IgG
  • Applikationshinweise

    Optimal dilution of the Glypican-3 antibody cocktail should be determined by the researcher.

    1. Staining of formalin-fixed tissues requires boiling tissue sections in 10  mM Tris with 1  mM EDTA,  pH 9.0, for 10-20 min followed by cooling at RT for 20 min
    2. The prediluted format is supplied in a dropper bottle and is optimized for use in IHC. After epitope retrieval step (if required), drip mAb solution onto the tissue section and incubate at RT for 30 min.\. Flow Cytometry: 0.5-1 μg/million cells in 0.1ml,Immunofluorescence: 0.5-1 μg/mL,Immunohistochemistry (FFPE): 0.5-1 μg/mL for 30 min at RT (1),Prediluted format : incubate for 30 min at RT (2)

    Beschränkungen

    Nur für Forschungszwecke einsetzbar
  • Konzentration

    1 mg/mL

    Buffer

    1 mg/mL in 1X PBS, BSA free, sodium azide free

    Konservierungsmittel

    Azide free

    Lagerung

    4 °C,-20 °C

    Informationen zur Lagerung

    Store the Glypican-3 antibody cocktail at 2-8°C (with azide) or aliquot and store at -20°C or colder (without azide).
  • Target

    Glypican 3 (GPC3)

    Andere Bezeichnung

    Glypican-3

    Hintergrund

    Glypican-3 (GPC3) is an integral membrane protein that is mutated in the Simpson-Golabi-Behmel syndrome (SGBS). SGBS is characterized by pre- and post-natal overgrowth and is a recessive X-linked condition. GPC3 may also be found in a secreted form. Anti-GPC3 has been identified as a useful tumor marker for the diagnosis of hepatocellular carcinoma (HCC), hepatoblastoma, melanoma, testicular germ cell tumors, and Wilm s tumor. In patients with HCC, GPC3 is overexpressed in neoplastic liver tissue and elevated in serum, but is undetectable in normal liver, benign liver, and the serum of healthy donors. GPC3 expression is also found to be higher in HCC liver tissue than in cirrhotic liver or liver with focal lesions such as dysplastic nodules and areas of hepatic adenoma (HA) with malignant transformation. In the context of testicular germ cell tumors, GPC3 expression is up regulated in certain histologic subtypes, specifically yolk sac tumors and choriocarcinoma. A high level of GPC3 expression has also been found in some types of embryonal tumors, such as Wilm s tumor and hepatoblastoma, with a low or undetectable expression in normal adjacent tissue. In patients with thyroid cancer, expression of GPC3 is dramatically enhanced in certain types of cancers: 100 % in follicular carcinoma and 70 % in papillary carcinoma. Expression of GPC3 in follicular carcinoma was significantly higher than that of follicular adenoma. In contrast, GPC 3 is not expressed in anaplastic carcinoma.

    Pathways

    Glycosaminoglycan Metabolic Process
Sie sind hier:
Chat with us!